http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102813703-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_988c614c175c00cc85991475e028fb71 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 |
filingDate | 2012-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37c7839003c3dbf91cd495904825cf92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a487c2c7421e566578b32c2f817fe284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b630a8f42f874d052df21c2cd2160e4 |
publicationDate | 2014-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102813703-B |
titleOfInvention | Medicine used for treating tinea pedis and mycosis ungualis |
abstract | The invention relates to a medicine used for treating tinea pedis and mycosis ungualis. The medicine comprises the following components in parts by weight or parts by volume: 10-15 parts of edible vinegar in parts by volume, 5-10 parts of edible salt in parts by weight and 5-8 parts of fresh folium eucalypti juice in parts by volume. The medicine used for treating the tinea pedis and the mycosis ungualis has the advantages that the use is safe; drug resistance cannot be generated; a treatment effect is good; the tinea pedis and the mycosis ungualis cannot relapse; and the environment is protected. |
priorityDate | 2012-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.